CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Blonanserin

布南色林 杂质对照品Blonanserin Impurities

28 个杂质条目28 impurity entries

本页汇总 布南色林 的 28 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 28 impurity reference standards of Blonanserin. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 布南色林(Blonanserin)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 分析方法Analytical MethodsDevelopment and validation of a stability-indicating gas chromatographic method for quality control of residual solvents in blonanserin: a novel atypical antipsychotic agent
    Journal of chromatographic science · 2012 · Peng M et al.  ·  PMID 22595261  ·  DOI
  2. 分析方法Analytical MethodsA Simple and Sensitive HPLC-MS/MS Assay for the Quantitation of Blonanserin and N-Desethyl Blonanserin in Rat Plasma and Its Application to Pharmacokinetic Study
    Journal of analytical methods in chemistry · 2022 · Huang SQ et al.  ·  PMID 35433070  ·  DOI
  3. 分析方法Analytical MethodsSimultaneous determination of blonanserin and its four metabolites in human plasma using ultra-performance liquid chromatography-tandem mass spectrometry
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2013 · Zhou Y et al.  ·  PMID 24099858  ·  DOI
  4. 分析方法Analytical MethodsSimultaneous determination of blonanserin and its metabolite in human plasma and urine by liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2012 · Wen YG et al.  ·  PMID 22818206  ·  DOI
  5. 分析方法Analytical MethodsBioequivalence of Blonanserin Tablets Under Fasting and Fed Conditions in Healthy Chinese Subjects
    Clinical pharmacology in drug development · 2024 · Lei Y et al.  ·  PMID 37740592  ·  DOI

布南色林 —— 原料药与杂质对照品Blonanserin — drug substance & impurities

共 29 个条目(含原料药本体)29 items incl. the drug substance
Blonanserin structure
原料药 APIAPI
布南色林Blonanserin
Blonanserin
CAS No.132810-10-7
Chemical FormulaC23H30FN3
Purity>95%询价On request
10mg25mg50mg100mg
Blonanserin Impurity 1 structure
1
布南色林杂质1Blonanserin Impurity 1
Blonanserin Impurity 1
CAS No.132810-75-4
Chemical FormulaC23H31N3
Purity>95%询价On request
10mg25mg50mg100mg
Blonanserin Impurity 2 structure
2
布南色林杂质2Blonanserin Impurity 2
Blonanserin Impurity 2
CAS No.1648791-23-4
Chemical FormulaC29H43N5
Purity>95%询价On request
10mg25mg50mg100mg
Blonanserin Impurity 3 structure
3
布南色林杂质3Blonanserin Impurity 3
Blonanserin Impurity 3
CAS No.132811-84-8
Chemical FormulaC21H26FN3
Purity>95%询价On request
10mg25mg50mg100mg
Blonanserin Impurity 8 structure
8
布南色林杂质8Blonanserin Impurity 8
Blonanserin Impurity 8
CAS No.132812-29-4
Chemical FormulaC23H31N3O
Purity>95%询价On request
10mg25mg50mg100mg
Blonanserin Impurity 9 structure
9
布南色林杂质9Blonanserin Impurity 9
Blonanserin Impurity 9
CAS No.2518376-10-6
Chemical FormulaC17H19FN2
Purity>95%询价On request
10mg25mg50mg100mg
Blonanserin Impurity 10 structure
10
布南色林杂质10Blonanserin Impurity 10
Blonanserin Impurity 10
CAS No.2243798-59-4
Chemical FormulaC21H28FN3
Purity>95%询价On request
10mg25mg50mg100mg
Blonanserin Impurity 11 structure
11
布南色林杂质11Blonanserin Impurity 11
Blonanserin Impurity 11
CAS No.2243797-97-7
Chemical FormulaC23H30FN3O2
Purity>95%询价On request
10mg25mg50mg100mg
Blonanserin Impurity 12 structure
12
布南色林杂质12Blonanserin Impurity 12
Blonanserin Impurity 12
CAS No.49860-76-6
Chemical FormulaC7H16N2
Purity>95%询价On request
10mg25mg50mg100mg
Blonanserin Impurity 14 structure
14
布南色林杂质14Blonanserin Impurity 14
Blonanserin Impurity 14
CAS No.1477480-40-2
Chemical FormulaC19H24FN3
Purity>95%询价On request
10mg25mg50mg100mg
Blonanserin Impurity 19 structure
19
布南色林杂质19Blonanserin Impurity 19
Blonanserin Impurity 19
CAS No.132810-87-8
Chemical FormulaC23H30ClN3
Purity>95%询价On request
10mg25mg50mg100mg
Blonanserin Impurity 21 structure
21
布南色林杂质21Blonanserin Impurity 21
Blonanserin Impurity 21
CAS No.142838-82-2
Chemical FormulaC23H30FN3O
Purity>95%询价On request
10mg25mg50mg100mg
Blonanserin Impurity 25 structure
25
布南色林杂质25Blonanserin Impurity 25
Blonanserin Impurity 25
CAS No.848301-76-8
Chemical FormulaC23H30FN3O
Purity>95%询价On request
10mg25mg50mg100mg
Blonanserin Impurity 28 structure
28
布南色林杂质28Blonanserin Impurity 28
Blonanserin Impurity 28
CAS No.132813-14-0
Chemical FormulaC17H17ClFN
Purity>95%询价On request
10mg25mg50mg100mg
Blonanserin Impurity 29 structure
29
布南色林杂质29Blonanserin Impurity 29
Blonanserin Impurity 29
CAS No.132812-72-7
Chemical FormulaC17H18FNO
Purity>95%询价On request
10mg25mg50mg100mg
Blonanserin Impurity 30 structure
30
布南色林杂质30Blonanserin Impurity 30
Blonanserin Impurity 30
CAS No.5308-25-8
Chemical FormulaC6H14N2
Purity>95%询价On request
10mg25mg50mg100mg
Blonanserin Impurity 31 structure
31
布南色林杂质31Blonanserin Impurity 31
Blonanserin Impurity 31
CAS No.132810-93-6
Chemical FormulaC24H33N3O
Purity>95%询价On request
10mg25mg50mg100mg
Blonanserin Impurity 32 (N-Nitroso Blonanserin Impurity 30) structure
32
布南色林杂质32 (N-亚硝基布南色林杂质30)Blonanserin Impurity 32 (N-Nitroso Blonanserin Impurity 30)
Blonanserin Impurity 32 (N-Nitroso Blonanserin Impurity 30)
CAS No.65504-33-8
Chemical FormulaC6H13N3O
Purity>95%询价On request
10mg25mg50mg100mg
Blonanserin Impurity 35 structure
35
布南色林杂质35Blonanserin Impurity 35
Blonanserin Impurity 35
CAS No.286-62-4
Chemical FormulaC8H14O
Purity>95%询价On request
10mg25mg50mg100mg
Blonanserin Impurity 38 structure
38
布南色林杂质38Blonanserin Impurity 38
Blonanserin Impurity 38
CAS No.3672-47-7
Chemical FormulaC10H9NO2
Purity>95%询价On request
10mg25mg50mg100mg
Blonanserin Impurity 39 structure
39
布南色林杂质39Blonanserin Impurity 39
Blonanserin Impurity 39
CAS No.4640-67-9
Chemical FormulaC9H6FNO
Purity>95%询价On request
10mg25mg50mg100mg
Blonanserin Impurity 40 structure
40
布南色林杂质40Blonanserin Impurity 40
Blonanserin Impurity 40
CAS No.671188-82-2
Chemical FormulaC9H8FNO2
Purity>95%询价On request
10mg25mg50mg100mg
Blonanserin Impurity 41 structure
41
布南色林杂质41Blonanserin Impurity 41
Blonanserin Impurity 41
CAS No.61815-42-7
Chemical FormulaC8H13Br
Purity>95%询价On request
10mg25mg50mg100mg
Blonanserin Impurity 42(Mixture of E/Z-isomers) structure
42
布南色林杂质42(混合E/Z构型)Blonanserin Impurity 42(Mixture of E/Z-isomers)
Blonanserin Impurity 42(Mixture of E/Z-isomers)
CAS No.4103-11-1
Chemical FormulaC8H13Br
Purity>95%询价On request
10mg25mg50mg100mg
Blonanserin Impurity 43 structure
43
布南色林杂质43Blonanserin Impurity 43
Blonanserin Impurity 43
CAS No.132813-13-9
Chemical FormulaC17H18ClN
Purity>95%询价On request
10mg25mg50mg100mg
Blonanserin Impurity 44 structure
44
布南色林杂质44Blonanserin Impurity 44
Blonanserin Impurity 44
CAS No.1214329-68-6
Chemical FormulaC17H10ClF2N
Purity>95%询价On request
10mg25mg50mg100mg
Blonanserin Impurity 45 structure
45
布南色林杂质45Blonanserin Impurity 45
Blonanserin Impurity 45
CAS No.132813-20-8
Chemical FormulaC18H20ClNO
Purity>95%询价On request
10mg25mg50mg100mg
Blonanserin Impurity 47 structure
47
布南色林杂质47Blonanserin Impurity 47
Blonanserin Impurity 47
CAS No.2243796-45-2
Chemical FormulaC23H28FN3O2
Purity>95%询价On request
10mg25mg50mg100mg
Blonanserin Impurity 52 (Mixture of E/Z-isomers) structure
52
布南色林杂质52 (混合E/Z构型)Blonanserin Impurity 52 (Mixture of E/Z-isomers)
Blonanserin Impurity 52 (Mixture of E/Z-isomers)
CAS No.55330-46-6
Chemical FormulaC9H7FN2
Purity>95%询价On request
10mg25mg50mg100mg
本品种含亚硝胺类杂质条目。亚硝胺杂质属于 ICH M7 关注的潜在致突变杂质,建议在方法开发中纳入专属性考察。This list includes nitrosamine entries. Nitrosamines are potential mutagenic impurities under ICH M7 and should be covered by a specific method.

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

布南色林 —— 研究文献与合成路线Blonanserin — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 布南色林 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Blonanserin. Titles link to the original records; copyright remains with the authors and publishers.

合成与制备工艺专利Synthesis & process patents

  1. High-purity blonanserin and preparation method thereof
    HAIPING ZHANG · 公开号 CN101531634CN101531634 · 2009

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

布南色林 杂质谱研究要点Blonanserin — impurity profiling notes

下面这些是拿到 布南色林 的 29 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 29 impurity entries for Blonanserin, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances